Search by Drug Name or NDC

NDC 00173-0876-14 Arnuity Ellipta 200 ug/1 Details

Arnuity Ellipta 200 ug/1

Arnuity Ellipta is a RESPIRATORY (INHALATION) POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is FLUTICASONE FUROATE.

MedlinePlus Drug Summary

Fluticasone oral inhalation is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children. It is in a class of medications called corticosteroids. Fluticasone works by decreasing swelling and irritation in the airways to allow for easier breathing.

Related Packages: 00173-0876-14
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fluticasone Oral Inhalation

Product Information

NDC	00173-0876
Product ID	0173-0876_424438a1-6362-4694-b20c-7d2fba714d20
Associated GPIs	44400033108030
GCN Sequence Number	072723
GCN Sequence Number Description	fluticasone furoate BLST W/DEV 200 MCG INHALATION
HIC3	B6M
HIC3 Description	GLUCOCORTICOIDS, ORALLY INHALED
GCN	37008
HICL Sequence Number	034756
HICL Sequence Number Description	FLUTICASONE FUROATE
Brand/Generic	Brand
Proprietary Name	Arnuity Ellipta
Proprietary Name Suffix	n/a
Non-Proprietary Name	fluticasone furoate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	POWDER
Route	RESPIRATORY (INHALATION)
Active Ingredient Strength	200
Active Ingredient Units	ug/1
Substance Name	FLUTICASONE FUROATE
Labeler Name	GlaxoSmithKline LLC
Pharmaceutical Class	Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA205625
Listing Certified Through	2024-12-31

Package

NDC 00173-0876-14 (00173087614)

Pricing Information	N/A
NDC Package Code	0173-0876-14
Billing NDC	00173087614
Package	1 INHALER in 1 CARTON (0173-0876-14) / 14 POWDER in 1 INHALER
Marketing Start Date	2014-08-20
NDC Exclude Flag	N